SCHEMBL352289

SCHEMBL352289

Cc1ccnc(-c2cc(CCN)ccn2)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR1 P32246 1/20 0.61
CCR5 P51681 1/20 0.61
CCR8 P51685 1/20 0.61
TAAR1 Q96RJ0 3/20 0.52
KARS1 Q15046 1/20 0.48
METAP2 P50579 1/20 0.45
LOXL2 Q9Y4K0 3/20 0.44
CYP2A6 P11509 2/20 0.44
CYP1A2 P05177 1/20 0.44
KDM4E B2RXH2 2/20 0.42
MEN1 O00255 1/20 0.42
NOS3 P29474 1/20 0.42
NOS1 P29475 1/20 0.42
NOS2 P35228 1/20 0.42
KMT2A Q03164 1/20 0.42
UHRF1 Q96T88 1/20 0.41
LOX P28300 1/20 0.40
NR3C2 P08235 2/20 0.38
BACE1 P56817 1/20 0.38
ATM Q13315 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7039186 0.90 CCR1 (0.57) CCR1CCR5CCR8TAAR1KARS1
SCHEMBL23037127 0.89 CCR1 (0.71) CCR1CCR5CCR8KARS1METAP2
SCHEMBL29693673 0.89 CCR1 (0.71) CCR1CCR5CCR8KARS1METAP2
SCHEMBL6494641 0.88 CCR1 (0.55) CCR1CCR5CCR8TAAR1KARS1
SCHEMBL6699910 0.87 CCR1 (0.53) CCR1CCR5CCR8TAAR1KARS1
SCHEMBL29978828 0.85 CCR1 (0.65) CCR1CCR5CCR8KARS1METAP2
SCHEMBL9160556 0.82 CCR1 (0.61) CCR1CCR5CCR8KARS1METAP2
SCHEMBL14590377 0.82 CCR1 (0.61) CCR1CCR5CCR8TAAR1METAP2
SCHEMBL24102155 0.82 CCR1 (0.61) CCR1CCR5CCR8METAP2LOXL2
SCHEMBL15082607 0.81 CCR1 (0.71) CCR1CCR5CCR8METAP2LOXL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8951400-B2 Chemistry used in biosensors OHMX CORPORATION (US) 2015-02-10 US disclosed
WO-2012012537-A1 NOVEL CHEMISTRY USED IN BIOSENSORS OHMX CORPORATION (US) 2012-01-26 WO disclosed
US-20120012472-A1 NOVEL CHEMISTRY USED IN BIOSENSORS OHMX CORPORATION (US) 2012-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120012472-A1 NOVEL CHEMISTRY USED IN BIOSENSORS SSBP1, OSGEP, OCIAD2 CCR1 4196/4885CCR5 2600/4885CCR8 3618/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.